BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17519623)

  • 1. Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists.
    Kazakov DV; Bisceglia M; Calonje E; Hantschke M; Kutzner H; Mentzel T; Michal M; Mukensnabl P; Spagnolo DV; Rütten A; Rose C; Urso C; Vazmitel M; Zelger B
    Am J Dermatopathol; 2007 Jun; 29(3):256-63. PubMed ID: 17519623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringocystadenoma papilliferum: report of 8 cases.
    Rammeh-Rommani S; Fezaa B; Chelbi E; Kammoun MR; Ben Jilani SB; Zermani R
    Pathologica; 2006 Jun; 98(3):178-80. PubMed ID: 17036946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Naevus sebaceus Jadassohn and syringocystadenoma papilliferum. Epithelial hamartoma of the skin].
    Mensing H; Jänner M
    Hautarzt; 1981 Mar; 32(3):130-5. PubMed ID: 6260706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
    Misago N; Narisawa Y
    J Dermatol; 2006 Jan; 33(1):2-9. PubMed ID: 16469077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
    Miller CJ; Ioffreda MD; Billingsley EM
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Syringocystadenoma papilliferum. A case located on the knee].
    Ndiaye B; Kane A; Develoux M; Dieng MT; Saccharin C
    Ann Dermatol Venereol; 1994; 121(4):323-4. PubMed ID: 7702252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
    Elsheikh TM; Asa SL; Chan JK; DeLellis RA; Heffess CS; LiVolsi VA; Wenig BM
    Am J Clin Pathol; 2008 Nov; 130(5):736-44. PubMed ID: 18854266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.
    Lin WL; Lin WC; Kuo TT; Chen CH; Hong HS
    Dermatol Surg; 2007 Jul; 33(7):876-9. PubMed ID: 17598859
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benign adnexal tumors of late occurrence in verrucoid-sebaceous nevus (Jadassohn). Apropos of 7 cases].
    Bonvalet D; Barrandon Y; Foix C; Civatte J
    Ann Dermatol Venereol; 1983; 110(4):337-42. PubMed ID: 6312866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verrucous carcinoma arising within syringocystadenoma papilliferum.
    Monticciolo NL; Schmidt JD; Morgan MB
    Ann Clin Lab Sci; 2002; 32(4):434-7. PubMed ID: 12458900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of zonal syringocystadenoma papilliferum of the axilla mimicking verruca vulgaris.
    Xu XL; Zhang GY; Zeng XS; Wang Q; Sun JF
    Am J Dermatopathol; 2010 Feb; 32(1):49-51. PubMed ID: 20098083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.